92 related articles for article (PubMed ID: 20350224)
1. Pigmented epithelioid melanocytoma: a recently described melanocytic tumour of low malignant potential.
Lim C; Murali R; McCarthy SW; Krivanek J; Scolyer RA
Pathology; 2010 Apr; 42(3):284-6. PubMed ID: 20350224
[No Abstract] [Full Text] [Related]
2. Expression of heat shock protein 105 and 70 in malignant melanoma and benign melanocytic nevi.
Park HS; Park CH; Choi BR; Lim MS; Heo SH; Kim CH; Kang SG; Whang KU; Cho MK
J Cutan Pathol; 2009 May; 36(5):511-6. PubMed ID: 19476517
[TBL] [Abstract][Full Text] [Related]
3. The effect of the sun on expression of beta-catenin, p16 and cyclin d1 proteins in melanocytic lesions.
Demirkan NC; Kesen Z; Akdag B; Larue L; Delmas V
Clin Exp Dermatol; 2007 Nov; 32(6):733-9. PubMed ID: 17868395
[TBL] [Abstract][Full Text] [Related]
4. Markers of melanocytic tumour progression.
Ruiter DJ; van Muijen GN
J Pathol; 1998 Dec; 186(4):340-2. PubMed ID: 10209480
[TBL] [Abstract][Full Text] [Related]
5. Pigmented epithelioid melanocytoma.
Ward JR; Brady SP; Tada H; Levin NA
Int J Dermatol; 2006 Dec; 45(12):1403-5. PubMed ID: 17184238
[No Abstract] [Full Text] [Related]
6. Malignant melanoma with neuroendocrine differentiation: clinical, histological, immunohistochemical and ultrastructural features of three cases.
Eyden B; Pandit D; Banerjee SS
Histopathology; 2005 Oct; 47(4):402-9. PubMed ID: 16178895
[TBL] [Abstract][Full Text] [Related]
7. The use and application of special techniques in assessing melanocytic tumours.
Busam KJ
Pathology; 2004 Oct; 36(5):462-9. PubMed ID: 15370117
[TBL] [Abstract][Full Text] [Related]
8. An unusual squamo-melanocytic tumor of uncertain biologic behavior: a variant of melanoma?
Pouryazdanparast P; Yu L; Johnson T; Fullen D
Am J Dermatopathol; 2009 Jul; 31(5):457-61. PubMed ID: 19542920
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays.
Bauer R; Wild PJ; Meyer S; Bataille F; Pauer A; Klinkhammer-Schalke M; Hofstaedter F; Bosserhoff AK
J Clin Pathol; 2006 Jul; 59(7):699-705. PubMed ID: 16565225
[TBL] [Abstract][Full Text] [Related]
10. Pigmented epithelioid melanocytoma: two case reports.
Howard B; Ragsdale B; Lundquist K
Dermatol Online J; 2005 Aug; 11(2):1. PubMed ID: 16150209
[TBL] [Abstract][Full Text] [Related]
11. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
12. Animal type melanoma: an unusual case with aggressive histological features?
Russo D; Vita G; Ilardi G; Siano M; Mascolo M
Pathol Res Pract; 2012 Mar; 208(3):169-71. PubMed ID: 22309954
[TBL] [Abstract][Full Text] [Related]
13. "Triggered trap": nevoid malignant melanoma.
McNutt NS
Semin Diagn Pathol; 1998 Aug; 15(3):203-9. PubMed ID: 9711670
[TBL] [Abstract][Full Text] [Related]
14. bcl-2 protein expression in melanocytic neoplasms of the skin.
Ramsay JA; From L; Kahn HJ
Mod Pathol; 1995 Feb; 8(2):150-4. PubMed ID: 7777475
[TBL] [Abstract][Full Text] [Related]
15. The dermal-based borderline melanocytic tumor: a categorical approach.
Magro CM; Crowson AN; Mihm MC; Gupta K; Walker MJ; Solomon G
J Am Acad Dermatol; 2010 Mar; 62(3):469-79. PubMed ID: 20159313
[TBL] [Abstract][Full Text] [Related]
16. Aggressive osteogenic desmoplastic melanoma: a case report.
Emanuel PO; Idrees MT; Leytin A; Kwon EJ; Phelps RG
J Cutan Pathol; 2007 May; 34(5):423-6. PubMed ID: 17448200
[TBL] [Abstract][Full Text] [Related]
17. Cdc7 expression in melanomas, Spitz tumors and melanocytic nevi.
Clarke LE; Fountaine TJ; Hennessy J; Bruggeman RD; Clarke JT; Mauger DT; Helm KF
J Cutan Pathol; 2009 Apr; 36(4):433-8. PubMed ID: 19278428
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value.
Väisänen A; Tuominen H; Kallioinen M; Turpeenniemi-Hujanen T
J Pathol; 1996 Nov; 180(3):283-9. PubMed ID: 8958806
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
[TBL] [Abstract][Full Text] [Related]
20. MSG-1 expression in benign and malignant melanocytic lesions of cutaneous and mucosal epithelium.
Sedghizadeh PP; Williams JD; Allen CM; Prasad ML
Med Sci Monit; 2005 Jul; 11(7):BR189-94. PubMed ID: 15990678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
